A comparison of Dabigatran, Enoxaparin and Rivaroxaban for venous thromboembolism prophylaxis

Phase 4

Conditions: Condition 1: Deep vein thromboembolism. Condition 2: Malignant neoplasm of lower respiratory tract.
Acute embolism and thrombosis of deep veins of lower extremity
Malignant neoplasm of lower respiratory tract, part unspecified
I82.4
C39.9

Registration Number: IRCT20200407046984N1

Lead Sponsor: Semnan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 57

Inclusion Criteria

Cancer patients referred to Kosar Hospital in Semnan (all metastatic patients with either progressive symptoms or in the phase of slowing down the disease)

Exclusion Criteria

High blood pressure (180/120 or more)
Moderate or severe hepatic insufficiency
Glomerular filtration rate (GFR) less than 30ml / min
Severe bleeding (requiring hospitalization)
Blood and hemorrhagic diseases include: hemophilia, Von Willebrand factor deficiency, problems of factors 2, 5, 7,10 and 12, types of Anemia, blood transfusions, Thrombocytopenia, Bernard-Soulier syndrome, Glanzmann, plaque pool storage deficiency syndrome, Vitamin K deficiency, Dysfibrinogenemia, Immune thrombocytopenia purpura (ITP), Acute lymphoblastic leukemia (ALL), Bleeding diathesis

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Thromboembolism. Timepoint: After seeing the initial symptoms taught to the patient himself. Method of measurement: Doppler ultrasound.;Bleeding. Timepoint: After seeing the initial symptoms taught to the patient himself. Method of measurement: PTT? Activated PTT? BT.

Secondary Outcome Measures